Carlo Cosmi
Azienda Ospedaliero Universitaria di Sassari(IT)
Publications by Year
Research Areas
Hemoglobinopathies and Related Disorders, Iron Metabolism and Disorders, Acute Lymphoblastic Leukemia research, Folate and B Vitamins Research, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial(2020)70 cited
- → Detection of myocardial iron overload by two-dimensional speckle tracking in patients with beta-thalassaemia major: a combined echocardiographic and T2* segmental CMR study(2017)29 cited
- → The prognostic value of biological markers in paediatric Hodgkin lymphoma(2015)18 cited
- → Population pharmacokinetics and dosing recommendations for the use of deferiprone in children younger than 6 years(2016)14 cited
- → Model-Based Optimisation of Deferoxamine Chelation Therapy(2015)12 cited
- → Early response does not predict outcome in children and adolescents with chronic myeloid leukaemia treated with high‐dose imatinib(2016)5 cited
- → Acute lymphoblastic leukemia in a nine-year-old girl with isodicentric chromosome 15 syndrome(2019)3 cited
- → S144 A MULTICENTRE, RANDOMIZED, NON‐INFERIORITY TRIAL COMPARING THE EFFICACY OF DEFERIPRONE VERSUS DEFERASIROX IN PEDIATRIC PATIENTS AFFECTED BY TRANSFUSION‐DEPENDENT HEMOGLOBINOPATHIES (DEEP‐2 TRIAL)(2019)2 cited
- Neuroblastoma in the first year of life. The Italian contribution to a study of the Internation Society of Paediatric Oncology Europe Neuroblastoma Group(2006)
- → Stratification for Age in Transfusion-Dependent Thalassemia(2018)